APTN · Adaptin Bio, Inc.
$6.27
At close · Aug 19
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Management has evaluated the Company's operating plan against its existing cash and determined that substantial doubt exists about the Company's ability to support its operations and fund its obligations for the next twelve months from the date of issuance of these condensed consolidated financial statements.”View the 10-Q filed Aug 13, 2026
Market Cap
$57.89M
Shares
9.23M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Net Income
-$5.17M
-65.5%
FY2025
Diluted EPS
-$0.66
+31.2%
FY2025
Operating Cash Flow
-$4.78M
-635.9%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 |
|---|---|---|---|---|
| $1.68M | $1.77M | $1.82M | — | |
| $3.71M | $3.64M | $745.29K | $85.59K | |
| $5.39M | $5.41M | $2.57M | — | |
| -$5.39M | -$5.41M | -$2.57M | -$85.59K | |
| $6639 | $72.66K | $341.05K | — | |
| -$6639 | $247.37K | -$552.67K | — | |
| -$5.4M | -$5.17M | -$3.12M | — | |
| -$5.4M | -$5.17M | -$3.12M | -$85.59K | |
| USD/shares | -$0.65 | -$0.66 | -$0.96 | -$0.02 |
| USD/shares | -$0.39 | -$0.66 | -$0.96 | -$0.02 |
| shares | — | 7.81M | 3.25M | 5M |
| shares | — | 7.81M | 3.25M | 5M |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
EV/EBIT
—
P/E (TTM)
—